HemaSense - About the company
HemaSense is an unfunded company based in Flagstaff (United States), founded in 2024 by Cody Hartman and Benjamin Trapp. It operates as a Developer of solutions for early detection and management of blood-related conditions. HemaSense has not raised any funding yet. The company has 13 active competitors, including 6 that are funded. Its top competitors include companies like Engineering for All, Membio and Beijing Zhizhen Biotechnology.
Company Details
Developer of solutions for early detection and management of blood-related conditions. It offers emaSense a non-invasive device to detect and measure bleeding and accelerate recovery in percutaneous intervention.
Key Metrics
Founded Year
2024
Location
Flagstaff, United States
Stage
Unfunded
Ranked
9th among 13 active competitors
Employee Count
5 as on Apr 30, 2026
Similar Companies
Sign up to download HemaSense's company profile
HemaSense's funding and investors
HemaSense has not raised any funding rounds yet.
HemaSense's founders and board of directors
Founder? Claim ProfileThe founders of HemaSense are Cody Hartman and Benjamin Trapp.
Here are the details of HemaSense's key team members:
- Cody Hartman: Co-Founder of HemaSense. Contact Info: 1 email address
- Benjamin Trapp: Co-Founder & CTO of HemaSense. Contact Info: 1 email address
View details of HemaSense's Founder profiles and Board Members
HemaSense's employee count trend
HemaSense has 5 employees as of Apr 26. Here is HemaSense's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
HemaSense's Competitors and alternates
Top competitors of HemaSense include Engineering for All, Membio and Beijing Zhizhen Biotechnology. Here is the list of Top 10 competitors of HemaSense, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Engineering for All 2016, Yokneam Illit (Israel), Series A | Provider of point of care diagnostic device | $7.4M | 44/100 | |
2nd | Developer of single-use bioreactors for cell and gene therapies | $280K | 40/100 | ||
3rd | Beijing Zhizhen Biotechnology 2017, Beijing (China), Series B | Provider of hematology testing instruments, reagents, and services | $17.8M | 38/100 | |
4th | Developer of smart devices for monitoring blood cells within the body | - | 36/100 | ||
5th | CIMON Medical 2018, Trondheim (Norway), Seed | Developer of a patented device for monitoring blood flow for early diagnosis | $6.81M | 35/100 | |
6th | Sphere Medical 2002, Cambridge (United Kingdom), Deadpooled | Monitoring devices for use in the ICU and OR | $11.9M | 33/100 | |
7th | Kalium Health 2018, Cambridge (United Kingdom), Seed | Developer of device for monitoring blood potassium | $1.22M | 33/100 | |
8th | SciLogica 2019, Denver (United States), Series A | Developer of a continuous blood parameter monitoring platform for critical care healthcare | $8.16M | - | 32/100 |
9th | HemaSense 2024, Flagstaff (United States), Unfunded | Developer of solutions for early detection and management of blood-related conditions | - | - | 28/100 |
10th | ToxCO 2019, Maidstone (United Kingdom), Unfunded | Developer of a breath monitoring device to detect carbon monoxide poisoning | - | - | 24/100 |
Looking for more details on HemaSense's competitors? Click here to see the top ones
HemaSense's Investments and acquisitions
HemaSense has made no investments or acquisitions yet.
News related to HemaSense
Media has covered HemaSense for 1 event in last 1 year.
•
Are you a Founder ?
FAQs about HemaSense
Explore our recently published companies
- Redwave - 2020 founded, Unfunded company
- Kamakshiconsultancy - Unfunded company
- Isabelespanol - Unfunded company
- Oaklandporttrans - 2019 founded, Unfunded company
- Promovingexperts - Unfunded company
- Race4Global - Unfunded company